Figuring out who and what is real or fake nowadays is getting to be a harder challenge in this AI-driven age. At CES, a buzzy startup with a Samsung pedigree, STAR Labs, introduced NEON as its first "artificial human." This "computationally created virtual being" sure looks and behaves like people you may come across every day, even if it doesn'tdo a whole lot right now, other than exhibit simple expressions and gestures on a large display. At this early preview stage, NEON is not quite a chatbot or robot and not quite a virtual assistant for your phone. But while NEON's can't be an exact copy or surrogate of an existing human, they are modeled after real people.

Warner Bros Studios is embracing artificial intelligence to make decisions about whether films and TV shows should get made and when they should premiere. The film studios has signed up to an AI-based software system provided by a company called Cinelytic to decide which content to commission and when it should be released. Cinelytic's new AI project management system was launched for the motion picture industry last year. Warner Bros will use the system to help make decisions around content and talent valuation, as first reported by The Hollywood Reporter. The platform can also assess the value of a star in any territory and how much a film is expected to make using several different release scenarios.

The majority of successful players in the automotive industry have transformed their business models over the past few years in response to the challenges of digitization. But while many are getting on track to digitize their core product offerings, the underlying business processes still show a high rate of manual work. Warranty handling is a prime example. Automotive manufacturers spend an estimated $50 billion on managing warranty claims each year1. In response to this and to accelerate digital transformation within key business processes of automotive manufacturers, MSX International (MSX) has joined forces with Boston Consulting Group Digital Ventures (BCGDV).

As Europe is set to initiate legislation on AI (which would make it the first region to pass hard laws for AI) @realDonaldTrump's White House is pushing forward with light regulations and urging allies to follow suit.

As we enter into 2020 and make predictions on what lies ahead in the New Year, it's time to look at how artificial intelligence could advance even more rapidly in the next 12 months. During the past few years, AI garnered a vast amount of global attention and became the most buzzworthy term of the decade as tech's next biggest thing. However, too much speculation led some to believe AI might not live up to its hype, and the workforce is eager to start seeing its potential and tangible results. This past year saw a move toward more practical applications in response to this concern. We saw AI become tangible to the enterprise, providing an efficient and scalable method to gain value from information.

Artificial Intelligence (AI) based on a combination of deep-learning algorithms and laser-imaging technology can be utilised to examine brain tissue and detect a brain tumour in near real-time according to a study published in Nature Medicine Journal on Monday. This recent AI technique can be a game-changer in intra-operative brain tumour diagnostics according to reports. The method is a combination of "Raman histology (SRH), a label-free optical imaging method and deep convolutional neural networks (CNNs) to predict diagnosis at the bedside in near real-time in an automated fashion," the study said. The AI method is also much faster. The neural networks have been trained using over 2.5 million SRH images to identify brain tumours using brain tissue in under 150 seconds, according to the report.

Health products powered by artificial intelligence, or AI, are streaming into our lives, from virtual doctor apps to wearable sensors and drugstore chatbots. IBM boasted that its AI could "outthink cancer." Others say computer systems that read X-rays will make radiologists obsolete. "There's nothing that I've seen in my 30-plus years studying medicine that could be as impactful and transformative" as AI, said Dr. Eric Topol, a cardiologist and executive vice president of Scripps Research in La Jolla, Calif. AI can help doctors interpret MRIs of the heart, CT scans of the head and photographs of the back of the eye, and could potentially take over many mundane medical chores, freeing doctors to spend more time talking to patients, Topol said. Even the Food and Drug Administration--which has approved more than 40 AI products in the past five years--says "the potential of digital health is nothing short of revolutionary."

Latin America is a region unique for its cultural and geographical diversity, as well as for its set of unique set of social challenges and opportunities. In the last century, Latin America has been slow to develop compared with other regions of the world such as North America or Europe. Some have even named the region the forgotten continent. Artificial intelligence provides an opportunity to accelerate the development of Latin America in the near future. This will only be true if AI receives adequate support and if initiatives are developed rapidly in the region.

The number of patents for inventions based on artificial intelligence, machine learning and deep learning continues to grow rapidly. Some of these inventions relate to AI technology per se, and some relate to the use of AI in specific applications, including many in healthcare, financial services and blockchain, among other industries. The USPTO has addressed various aspects of intellectual property issues with these technologies in various ways, including in an event it hosted entitled "Artificial Intelligence: Intellectual Property Policy Considerations (January 2019)." Due to some of the unique issues with these technologies, the USPTO is considering whether it should make any changes to how it handles examination of these applications. As part of this analysis, the USPTO issued a request for public comments on protection and examination of these inventions.